Literature DB >> 30504423

CCR2 Signaling Selectively Regulates IFN-α: Role of β-Arrestin 2 in IFNAR1 Internalization.

Dionna W Williams1,2, Lauren C Askew3, Elonna Jones3, Janice E Clements3,4,5.   

Abstract

An integral component of the antiviral response, type I IFNs require regulation to modulate immune activation. We identify β-arrestin 2 as a key modulator of type I IFN in primary human macrophages, an essential component of the innate immune response. β-Arrestin 2 was selectively activated by CCL2/CCR2 signaling, which induced a decrease in IFN-α, but not IFN-β expression. Small interfering RNA knockdown of β-arrestin 2 demonstrated its role in IFNAR1 internalization, as well as STAT1 and IRF3 activation. As a result, cytokine responses were not propagated following HIV infection and TLR3 activation. However, remnants of IFN signaling remained intact, despite β-arrestin 2 activation, as IFN-β, IFN-γ, IFN-λ1, IRF7, TRAIL, and MxA expression were sustained. Similar effects of β-arrestin 2 on IFN signaling occurred in hepatocytes, suggesting that arrestins may broadly modulate IFN responses in multiple cell types. In summary, we identify a novel role of β-arrestin 2 as an integral regulator of type I IFN through its internalization of IFNAR1 and a subsequent selective loss of downstream IFN signaling.
Copyright © 2018 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30504423      PMCID: PMC6310093          DOI: 10.4049/jimmunol.1800598

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  56 in total

Review 1.  Regulation of immunity and oncogenesis by the IRF transcription factor family.

Authors:  David Savitsky; Tomohiko Tamura; Hideyuki Yanai; Tadatsugu Taniguchi
Journal:  Cancer Immunol Immunother       Date:  2010-01-05       Impact factor: 6.968

2.  Simian immunodeficiency virus infection in the brain and lung leads to differential type I IFN signaling during acute infection.

Authors:  Luna Alammar; Lucio Gama; Janice E Clements
Journal:  J Immunol       Date:  2011-03-02       Impact factor: 5.422

Review 3.  The β-Arrestins: Multifunctional Regulators of G Protein-coupled Receptors.

Authors:  Jeffrey S Smith; Sudarshan Rajagopal
Journal:  J Biol Chem       Date:  2016-03-16       Impact factor: 5.157

Review 4.  Neurologic Phenotypes Associated with Mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, ADAR1, and IFIH1: Aicardi-Goutières Syndrome and Beyond.

Authors:  John H Livingston; Yanick J Crow
Journal:  Neuropediatrics       Date:  2016-09-19       Impact factor: 1.947

5.  Distinct poly(I-C) and virus-activated signaling pathways leading to interferon-beta production in hepatocytes.

Authors:  Kui Li; Zihong Chen; Nobuyuki Kato; Michael Gale; Stanley M Lemon
Journal:  J Biol Chem       Date:  2005-02-28       Impact factor: 5.157

Review 6.  Type I interferon pathway in CNS homeostasis and neurological disorders.

Authors:  Thomas Blank; Marco Prinz
Journal:  Glia       Date:  2017-05-18       Impact factor: 7.452

7.  Differential viral induction of distinct interferon-alpha genes by positive feedback through interferon regulatory factor-7.

Authors:  I Marié; J E Durbin; D E Levy
Journal:  EMBO J       Date:  1998-11-16       Impact factor: 11.598

8.  Basal ubiquitin-independent internalization of interferon alpha receptor is prevented by Tyk2-mediated masking of a linear endocytic motif.

Authors:  K G Suresh Kumar; Bentley Varghese; Anamika Banerjee; Darren P Baker; Stefan N Constantinescu; Sandra Pellegrini; Serge Y Fuchs
Journal:  J Biol Chem       Date:  2008-05-12       Impact factor: 5.157

9.  Mechanisms of HIV entry into the CNS: increased sensitivity of HIV infected CD14+CD16+ monocytes to CCL2 and key roles of CCR2, JAM-A, and ALCAM in diapedesis.

Authors:  Dionna W Williams; Tina M Calderon; Lillie Lopez; Loreto Carvallo-Torres; Peter J Gaskill; Eliseo A Eugenin; Susan Morgello; Joan W Berman
Journal:  PLoS One       Date:  2013-07-26       Impact factor: 3.240

10.  Gain-of-function mutations in IFIH1 cause a spectrum of human disease phenotypes associated with upregulated type I interferon signaling.

Authors:  Gillian I Rice; Yoandris Del Toro Duany; Emma M Jenkinson; Gabriella Ma Forte; Beverley H Anderson; Giada Ariaudo; Brigitte Bader-Meunier; Eileen M Baildam; Roberta Battini; Michael W Beresford; Manuela Casarano; Mondher Chouchane; Rolando Cimaz; Abigail E Collins; Nuno Jv Cordeiro; Russell C Dale; Joyce E Davidson; Liesbeth De Waele; Isabelle Desguerre; Laurence Faivre; Elisa Fazzi; Bertrand Isidor; Lieven Lagae; Andrew R Latchman; Pierre Lebon; Chumei Li; John H Livingston; Charles M Lourenço; Maria Margherita Mancardi; Alice Masurel-Paulet; Iain B McInnes; Manoj P Menezes; Cyril Mignot; James O'Sullivan; Simona Orcesi; Paolo P Picco; Enrica Riva; Robert A Robinson; Diana Rodriguez; Elisabetta Salvatici; Christiaan Scott; Marta Szybowska; John L Tolmie; Adeline Vanderver; Catherine Vanhulle; Jose Pedro Vieira; Kate Webb; Robyn N Whitney; Simon G Williams; Lynne A Wolfe; Sameer M Zuberi; Sun Hur; Yanick J Crow
Journal:  Nat Genet       Date:  2014-03-30       Impact factor: 38.330

View more
  5 in total

1.  Extracellular Nucleotides and Histamine Suppress TLR3- and RIG-I-Mediated Release of Antiviral IFNs from Human Airway Epithelial Cells.

Authors:  Timothy S Kountz; Assel Biyasheva; Robert P Schleimer; Murali Prakriya
Journal:  J Immunol       Date:  2022-04-22       Impact factor: 5.426

2.  E3-ubiquitin ligase TRIM6 aggravates myocardial ischemia/reperfusion injury via promoting STAT1-dependent cardiomyocyte apoptosis.

Authors:  Guangwei Zeng; Chen Lian; Pei Yang; Mingming Zheng; He Ren; Haiyan Wang
Journal:  Aging (Albany NY)       Date:  2019-06-06       Impact factor: 5.682

Review 3.  Nef-induced CCL2 Expression Contributes to HIV/SIV Brain Invasion and Neuronal Dysfunction.

Authors:  Michael H Lehmann; Jonas M Lehmann; Volker Erfle
Journal:  Front Immunol       Date:  2019-10-15       Impact factor: 7.561

Review 4.  Targeting GPCRs Against Cardiotoxicity Induced by Anticancer Treatments.

Authors:  Anais Audebrand; Laurent Désaubry; Canan G Nebigil
Journal:  Front Cardiovasc Med       Date:  2020-01-24

Review 5.  Interferon Receptor Trafficking and Signaling: Journey to the Cross Roads.

Authors:  Natacha Zanin; Christine Viaris de Lesegno; Christophe Lamaze; Cedric M Blouin
Journal:  Front Immunol       Date:  2021-01-20       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.